QUEENS WALK PRACTICE — All Prescriptions & Medications — Page 6
Practice Code: E85057 | LONDON, W5 1TP
Showing results 251-300 of 501
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 59 | 30.7K | £215 | -35.3% ▼ | |
| 59 | 3,356 | £392 | -26.7% ▼ | |
| Nicotine | 58 | 3,106 | £1.2K | +2.7% ▲ |
| Fludrocortisone acetate | 57 | 1,782 | £248 | -46.0% ▼ |
| Dorzolamide | 57 | 4,580 | £1.8K | -31.4% ▼ |
| 57 | 57 | £251 | +11.1% ▲ | |
| Lorazepam | 56 | 1,568 | £248 | -60.7% ▼ |
| Methylprednisolone acetate | 56 | 64 | £216 | -51.5% ▼ |
| Emollient bath and shower preparations | 56 | 24.6K | £357 | -10.8% ▼ |
| Mefenamic acid | 55 | 2,724 | £565 | +21.7% ▲ |
| Clotrimazole | 54 | 1,220 | £95 | -44.3% ▼ |
| Prazosin hydrochloride | 53 | 848 | £42 | +214.7% ▲ |
| Colestyramine | 53 | 2,907 | £1.3K | +84.0% ▲ |
| Chlorphenamine maleate | 53 | 5,312 | £137 | -52.0% ▼ |
| Bempedoic acid | 52 | 2,072 | £3.9K | +58.6% ▲ |
| Lofepramine hydrochloride | 52 | 364 | £163 | +73.8% ▲ |
| Biphasic isophane insulin | 52 | 395 | £1.7K | -53.4% ▼ |
| Fluticasone furoate/vilanterol | 50 | 88 | £2.1K | -67.7% ▼ |
| Quinine sulfate | 50 | 3,024 | £516 | -82.7% ▼ |
| Peppermint oil | 49 | 2,308 | £293 | -38.4% ▼ |
| Glycerol | 49 | 1,459 | £264 | +39.7% ▲ |
| Dulaglutide | 49 | 410 | £7.5K | -57.2% ▼ |
| Valsartan | 48 | 4,480 | £821 | -18.5% ▼ |
| Dipyridamole | 48 | 2,880 | £600 | +87.0% ▲ |
| Terbutaline sulphate | 48 | 55 | £434 | -11.5% ▼ |
| Duloxetine hydrochloride | 48 | 2,131 | £450 | -6.3% ▼ |
| Fluorouracil (Sunscreen) | 48 | 1,920 | £1.5K | +31.8% ▲ |
| Powder amino acid formula (0913107) | 47 | 141.2K | £8.9K | +42.3% ▲ |
| 47 | 2,158 | £847 | -54.0% ▼ | |
| 46 | 46 | £414 | +42.0% ▲ | |
| Hyoscine butylbromide | 45 | 3,426 | £264 | -80.7% ▼ |
| Bisacodyl | 45 | 4,020 | £246 | -65.7% ▼ |
| 45 | 1,601 | £4.2K | +33.2% ▲ | |
| 45 | 162 | £1.1K | +61.7% ▲ | |
| Insulin degludec | 44 | 377 | £4.2K | -60.0% ▼ |
| Bempedoic acid/Ezetimibe | 43 | 2,968 | £5.6K | -29.6% ▼ |
| Azithromycin | 43 | 1,092 | £328 | -66.1% ▼ |
| Zolmitriptan | 42 | 320 | £1.3K | -35.3% ▼ |
| Terbinafine hydrochloride | 42 | 990 | £177 | +13.2% ▲ |
| Procyclidine hydrochloride | 41 | 2,812 | £108 | -71.0% ▼ |
| Risedronate sodium | 41 | 464 | £122 | -66.2% ▼ |
| Chlorhexidine gluconate | 41 | 13.6K | £340 | +38.8% ▲ |
| Ciprofloxacin | 40 | 1,704 | £183 | +0.3% vs avg |
| Hydroxychloroquine sulfate | 39 | 3,544 | £312 | -79.9% ▼ |
| Pimecrolimus | 39 | 1,880 | £1.1K | +130.3% ▲ |
| Ivermectin | 39 | 1,830 | £1.1K | +83.4% ▲ |
| 39 | 1,282 | £3.5K | -11.3% ▼ | |
| Powder extensively hydrolysed formula (0913101) | 38 | 96.8K | £2.7K | -47.3% ▼ |
| Nicorandil | 37 | 3,540 | £560 | -74.3% ▼ |
| Fluconazole | 37 | 333 | £81 | -52.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.